JP2002526409A - 光障害性網膜変性疾患処置用組成物 - Google Patents

光障害性網膜変性疾患処置用組成物

Info

Publication number
JP2002526409A
JP2002526409A JP2000573361A JP2000573361A JP2002526409A JP 2002526409 A JP2002526409 A JP 2002526409A JP 2000573361 A JP2000573361 A JP 2000573361A JP 2000573361 A JP2000573361 A JP 2000573361A JP 2002526409 A JP2002526409 A JP 2002526409A
Authority
JP
Japan
Prior art keywords
lower alkyl
retinal
alkyl group
degenerative disease
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2000573361A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002526409A5 (https=
Inventor
隆司 上野
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sucampo GmbH
Original Assignee
Sucampo GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sucampo GmbH filed Critical Sucampo GmbH
Publication of JP2002526409A publication Critical patent/JP2002526409A/ja
Publication of JP2002526409A5 publication Critical patent/JP2002526409A5/ja
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
JP2000573361A 1998-10-02 1999-09-29 光障害性網膜変性疾患処置用組成物 Withdrawn JP2002526409A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US10297298P 1998-10-02 1998-10-02
US60/102,972 1998-10-02
US11070098P 1998-12-03 1998-12-03
US60/110,700 1998-12-03
PCT/JP1999/005321 WO2000020002A1 (en) 1998-10-02 1999-09-29 Composition for treatment of light-injured retinal degeneration disease

Publications (2)

Publication Number Publication Date
JP2002526409A true JP2002526409A (ja) 2002-08-20
JP2002526409A5 JP2002526409A5 (https=) 2006-11-24

Family

ID=26799937

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000573361A Withdrawn JP2002526409A (ja) 1998-10-02 1999-09-29 光障害性網膜変性疾患処置用組成物

Country Status (8)

Country Link
US (1) US6248759B1 (https=)
EP (1) EP1117404A1 (https=)
JP (1) JP2002526409A (https=)
AR (1) AR020681A1 (https=)
AU (1) AU5998399A (https=)
BR (1) BR9914254A (https=)
CA (1) CA2346086A1 (https=)
WO (1) WO2000020002A1 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007520480A (ja) * 2004-01-14 2007-07-26 ラヴィファーム・ラボラトリーズ・インク 少なくとも一つの脂肪酸を含むジヒドロピリジンタイプのカルシウムアンタゴニスト用の経皮的デリバリー器具

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2585574B1 (fr) * 1985-07-31 1988-09-09 Corbiere Jerome Nouvelles compositions pharmaceutiques anti-glaucomateuses a base de 1,4-dihydropyridines et leur procede d'obtention
WO1990006123A1 (en) * 1988-12-05 1990-06-14 Houston Biotechnology Incorporated Therapeutic use of calcium entry blockers in retinal or optic nerve dysfunction
FR2642307A1 (fr) * 1989-01-27 1990-08-03 Corbiere Jerome Medicament pour le traitement des maladies degeneratives de la retine et notamment des maladies conditionnees genetiquement, et un procede pour leur obtention
JP3041923B2 (ja) * 1990-06-27 2000-05-15 藤沢薬品工業株式会社 ジヒドロピリジン化合物を含有する抗炎症および活性酸素産生抑制剤
US5691360A (en) * 1993-12-08 1997-11-25 Alcon Laboratories, Inc. Compounds having both potent calcium antagonist and antioxidant activity and use thereof as cytoprotective agents
EP0911027A4 (en) 1996-04-26 2000-11-29 Fujisawa Pharmaceutical Co THE DIHYDROPYRIDINE CONTAINS TO IMPROVE THE CIRCULATION OF THE EYE-SURROUNDING TISSUE
JPH1072347A (ja) 1996-05-27 1998-03-17 Otsuka Pharmaceut Co Ltd 眼血管血流改善剤

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007520480A (ja) * 2004-01-14 2007-07-26 ラヴィファーム・ラボラトリーズ・インク 少なくとも一つの脂肪酸を含むジヒドロピリジンタイプのカルシウムアンタゴニスト用の経皮的デリバリー器具

Also Published As

Publication number Publication date
WO2000020002A1 (en) 2000-04-13
BR9914254A (pt) 2001-07-03
EP1117404A1 (en) 2001-07-25
CA2346086A1 (en) 2000-04-13
AU5998399A (en) 2000-04-26
AR020681A1 (es) 2002-05-22
US6248759B1 (en) 2001-06-19

Similar Documents

Publication Publication Date Title
US20240207246A1 (en) Pharmaceutical composition
US20210052599A1 (en) Drug therapy for preventing or treating glaucoma
JP2008308489A (ja) ロピニロール又はその塩を有効成分として含有する後眼部疾患の予防又は治療剤
US20030216431A1 (en) Ophthalmic pharmaceutical compositions and methods for treating ocular inflammation
JP2024144702A (ja) 網膜疾患の治療のための眼内または経口投与用医薬組成物
JP2010215667A (ja) 外網膜の疾患を処置する薬剤を製造するためのβ−アドレナリン作用受容体アンタゴニストの使用
EP1004307B1 (en) Ophthalmic composition
SK284371B6 (sk) Použitie oftalmologickej kompozície obsahujúcej účinné množstvo lokálneho inhibítora anhydrázy kyseliny uhličitej na prípravu liečiva
JPH06316519A (ja) 薬剤で誘導される瞳孔拡大を抑制し又は拡大された瞳孔を 縮小するための、一定のスルファモイル置換フェネチルア ミン誘導体の使用、及びそれに用いる局部的投与組成物
EP0647445B1 (en) Composition for prophylaxis and treatment of myopia
JP2001519394A (ja) 緑内障の局所治療用フルナリジンの使用法
CA2528148A1 (en) Coumarin derivatives for the treatment of ophthalmic disorders
JP2002526409A (ja) 光障害性網膜変性疾患処置用組成物
WO2011149012A1 (ja) イソキノリンスルホニル誘導体を有効成分として含有する網脈絡膜変性疾患の予防または治療剤、網脈絡膜変性疾患の予防または治療方法、イソキノリンスルホニル誘導体またはその医薬的に許容される塩、ならびにその使用
JP3066561B2 (ja) 近視予防・治療剤
WO2002040028A1 (fr) Gouttes pour les yeux en gel antibacterien
JPWO2005079792A1 (ja) 重症糖尿病網膜症の予防又は治療剤
KR20240060626A (ko) 드라이 아이의 예방 및/또는 치료를 위한 의약
WO2010010939A1 (ja) 加齢黄斑変性の予防又は治療剤
JP2004262812A (ja) 眼圧低下剤
JP2004250347A (ja) 網膜虚血に基づく疾患の治療および／又は予防剤
JP3530542B2 (ja) 眼科用アルガトロバン製剤
JPWO2002051431A1 (ja) 網膜虚血に基づく疾患の治療および／または予防剤
JP2009079041A (ja) リチウム塩を有効成分として含有する後眼部疾患の治療又は予防剤
WO2000061148A1 (en) Inhibitors for optic hypofunction caused by optic nerve cell injury induced by factors other than optic circulatory disorder

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20060927

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20060927

A761 Written withdrawal of application

Free format text: JAPANESE INTERMEDIATE CODE: A761

Effective date: 20090219